Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Streinu-Cercel A, Castagna A, Chang SC, Chen YS, Koullias Y, Mozaffarian A, Hyland RH, Humeniuk R, Caro L, Davies S, Rodriguez L, Hedskog C, Chen S, Etchevers K, Behenna-Renton N, Llewellyn J, Osinusi A, Duff F, Barrat Hernández A, McNally D, Simon-Campos JA, Leal FE, Fouche LF, González Del Castillo JM. Streinu-Cercel A, et al. Among authors: davies s. Clin Infect Dis. 2025 Jul 22:ciaf406. doi: 10.1093/cid/ciaf406. Online ahead of print. Clin Infect Dis. 2025. PMID: 40694627
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.
Humeniuk R, Juneja K, Chen S, Ellis S, Anoshchenko O, Xiao D, Share A, Johnston M, Davies S, DeZure A, Llewellyn J, Osinusi A, Winter H, Girish S, Palaparthy R, Dresser M. Humeniuk R, et al. Among authors: davies s. Clin Transl Sci. 2023 Nov;16(11):2276-2288. doi: 10.1111/cts.13627. Epub 2023 Sep 25. Clin Transl Sci. 2023. PMID: 37688349 Free PMC article. Clinical Trial.
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.
Anoshchenko O, Abdelghany M, Lichtman A, Duan R, Chen H, Shaik NA, Peng CC, Yue Q, Subramanian R, Hyland RH, Davies S, Castellanos K, Mak L, Shen G, Xiao D, Caro L, Winter H, Llewellyn J, Humeniuk R. Anoshchenko O, et al. Among authors: davies s. Clin Pharmacol Ther. 2024 Nov;116(5):1231-1239. doi: 10.1002/cpt.3337. Epub 2024 Jun 28. Clin Pharmacol Ther. 2024. PMID: 38940465 Clinical Trial.
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Ogbuagu O, Goldman JD, Gottlieb RL, Singh U, Shinkai M, Acloque G, Fusco DN, Gonzalez E, Kumar P, Luetkemeyer A, Lichtman A, Mozaffarian A, Koullias Y, Hyland RH, Llewellyn J, Osinusi A, Duff F, Humeniuk R, Caro L, Davies S, Rodriguez L, Hedskog C, Chen S, Etchevers K, Nadig P, Kohli A; OAKTREE Trial Investigators. Ogbuagu O, et al. Among authors: davies s. Lancet Infect Dis. 2025 Dec;25(12):1282-1292. doi: 10.1016/S1473-3099(25)00238-5. Epub 2025 Jul 14. Lancet Infect Dis. 2025. PMID: 40675167 Clinical Trial.
The Saving Young Lives Program, Real World Solutions to Real World Problems.
Cullis B, Chan A, Finkelstein F, Boyer A, Davies S, Bonilla-Felix M, Hidalgo G, McCulloch M, Moorthy M, Smoyer WE. Cullis B, et al. Among authors: davies s. Clin J Am Soc Nephrol. 2025 Dec 12. doi: 10.2215/CJN.0000000983. Online ahead of print. Clin J Am Soc Nephrol. 2025. PMID: 41385287 No abstract available.
One Health for all: Implementing international frameworks with local communities.
Ruwet M, Rourke M, Afsana K, Ahamad F, Borja E, Lee K, Wenham C, Woyengu N, Davies SE. Ruwet M, et al. Among authors: davies se. PLOS Glob Public Health. 2025 Dec 11;5(12):e0005520. doi: 10.1371/journal.pgph.0005520. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 41379855 Free PMC article. No abstract available.
4,447 results